West Pharmaceutical Services, Inc.
WST
$251.38
$0.130.05%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.05% | 4.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.05% | 4.97% | |||
| Cost of Revenue | -1.80% | 3.59% | |||
| Gross Profit | 3.26% | 7.45% | |||
| SG&A Expenses | 6.33% | 6.98% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 33.33% | 0.00% | |||
| Total Operating Expenses | 0.32% | 3.68% | |||
| Operating Income | -0.91% | 9.88% | |||
| Income Before Tax | -4.94% | 7.41% | |||
| Income Tax Expenses | -2.06% | 12.58% | |||
| Earnings from Continuing Operations | -5.64% | 6.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.64% | 6.22% | |||
| EBIT | -0.91% | 9.88% | |||
| EBITDA | 1.10% | 8.64% | |||
| EPS Basic | -5.78% | 6.22% | |||
| Normalized Basic EPS | 0.81% | 7.74% | |||
| EPS Diluted | -5.21% | 5.49% | |||
| Normalized Diluted EPS | 0.81% | 7.60% | |||
| Average Basic Shares Outstanding | 0.14% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.14% | 0.14% | |||
| Dividend Per Share | 4.76% | 0.00% | |||
| Payout Ratio | 0.11% | -0.06% | |||